| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/27/1997 | US5633141 Assaying platelet factor 4 neutrophil agonists |
| 05/27/1997 | US5633139 Polypeptides |
| 05/27/1997 | US5633136 ALL-1 polynucleotides for leukemia detection and treatment |
| 05/27/1997 | US5633135 Chimeric nucleic acids and proteins resulting from ALL-1 region chromosome abnormalities |
| 05/27/1997 | US5633076 Maturing bovine ovum in vitro, forming zygote, introducing transgene into zygote, maturing to form embryo, transplanting embryo into female bovine |
| 05/27/1997 | US5632994 Fas associated proteins |
| 05/27/1997 | US5632993 Immunogens and the use thereof for obtaining antibodies against HbA1c |
| 05/27/1997 | US5632992 Process for the expression of herpes simplex virus type 1 glycoprotein E and method of use |
| 05/27/1997 | US5632991 Antibodies specific for E-selectin and the uses thereof |
| 05/27/1997 | US5632989 Screening with a monoclonal antibodies |
| 05/27/1997 | US5632988 Containing the specific amino acid sequence arg-arg-lys-trp-gln in their structure |
| 05/27/1997 | US5632987 Bacillus thuringiensis toxins active against corn rootworm larvae |
| 05/27/1997 | US5632986 Annexin-urokinase |
| 05/27/1997 | US5632983 Method for treating secondary immunodeficiency |
| 05/27/1997 | CA1339047C Production of erythropoietin |
| 05/25/1997 | CA2191023A1 Process for the utilization of biological matrices comprising peptides or proteins |
| 05/22/1997 | WO1997018475A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 05/22/1997 | WO1997018333A1 Disruption of expression of multiple alleles of mammalian genes |
| 05/22/1997 | WO1997018332A1 Regulation of cancer-causing tyrosine kinases by potassium ion conductance |
| 05/22/1997 | WO1997018318A1 Method for gene introduction into target cells by retrovirus |
| 05/22/1997 | WO1997018317A1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof |
| 05/22/1997 | WO1997018316A1 Expression system in microorganism and its use for expressing heterologous and homologous proteins |
| 05/22/1997 | WO1997018315A1 Hybrid factor viii with modified activity |
| 05/22/1997 | WO1997018314A1 Process for the preparation of peptides by way of streptavidin fusion proteins |
| 05/22/1997 | WO1997018311A1 Polyvalent anti-dengue vaccine |
| 05/22/1997 | WO1997018310A1 Plant gene involved in auxin related signalling pathways |
| 05/22/1997 | WO1997018309A1 E6 binding proteins |
| 05/22/1997 | WO1997018308A2 K-atp channel protein and methods relating to it |
| 05/22/1997 | WO1997018307A1 Fas ligand fusion protein |
| 05/22/1997 | WO1997018306A1 Crf analogs and their use in photoaffinity labeling of crf receptors |
| 05/22/1997 | WO1997018305A2 Method to prepare drug-resistant, non-malignant hematopoietic cells |
| 05/22/1997 | WO1997018304A1 Methods for modulation of cholesterol transport |
| 05/22/1997 | WO1997018303A1 Rac-proteine kinase as therapeutic agent or in diagnostics |
| 05/22/1997 | WO1997018301A1 Synthetic hpv11 virus-like particles |
| 05/22/1997 | WO1997018241A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 05/22/1997 | WO1997018240A1 Glial cell line-derived neurotrophic factor receptors |
| 05/22/1997 | WO1997018239A1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 05/22/1997 | WO1997018238A2 Crf analogs |
| 05/22/1997 | WO1997018237A1 Chemokine from niddm pancreas |
| 05/22/1997 | WO1997018236A1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX |
| 05/22/1997 | WO1997018234A2 Extraction of proteins into carbon dioxide |
| 05/22/1997 | WO1997018233A1 Method for producing a correctly folded, biological active recombinant protein |
| 05/22/1997 | WO1997018232A2 Peptides derived from the oncogene proteine bcr-abl expressed by leukemic cells and utilisation thereof for the therapy of human leukemiae |
| 05/22/1997 | WO1997018230A1 Cloning and expression of beta app-c100 receptor (c100-r) |
| 05/22/1997 | WO1997018229A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 05/22/1997 | WO1997018228A1 The transcriptional promoter of the obesity gene |
| 05/22/1997 | WO1997018227A1 Type ix collagen and fragments thereof |
| 05/22/1997 | WO1997018225A1 Salmonella secreted proteins and uses thereof |
| 05/22/1997 | WO1997018224A1 Human stem cell antigen 2 |
| 05/22/1997 | WO1997018000A1 S-nitroso-hemoglobin and therapeutic uses thereof |
| 05/22/1997 | WO1997017991A1 Remedy for acute hepatic insufficiency |
| 05/22/1997 | WO1997017990A1 Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury |
| 05/22/1997 | WO1997017988A1 Type ix collagen and chimeras |
| 05/22/1997 | WO1997017987A1 C9 complement inhibitor |
| 05/22/1997 | WO1997017984A1 Oligodendrocyte-specific protein and method for treating disease |
| 05/22/1997 | WO1997017982A1 Methods and compositions for hair growth promotion |
| 05/22/1997 | WO1997017937A2 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
| 05/22/1997 | WO1997017842A1 Production of somatic mosaicism in mammals using a recombinatorial substrate |
| 05/22/1997 | WO1997009344A3 Librairies of backbone-cyclized peptidomimetics |
| 05/22/1997 | WO1997008314A3 Telomere repeat binding factor and diagnostic and therapeutic use thereof |
| 05/22/1997 | WO1997008304A3 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease |
| 05/22/1997 | WO1997007387A3 A method and kit for evaluating the metastatic tendency of tumors |
| 05/22/1997 | WO1997007213A3 Assay for identifying genes causing chromosome non-disjunction |
| 05/22/1997 | WO1997007135A3 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 05/22/1997 | WO1997005468A3 A confirmatory serodiagnostic assay for infectious diseases |
| 05/22/1997 | WO1997005252A3 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 05/22/1997 | WO1997005241A3 Methods and compositions for identifying morphogen analogs |
| 05/22/1997 | WO1997002004A3 Methods for treating diabetes |
| 05/22/1997 | WO1996041606A3 Improved pharmaceutical compositions for gene therapy |
| 05/22/1997 | CA2240192A1 Methods for screening compounds that modulate cholesterol transport |
| 05/22/1997 | CA2238007A1 Cloning and expression of .beta.app-c100 receptor (c100-r) |
| 05/22/1997 | CA2237998A1 Chemokine from niddm pancreas |
| 05/22/1997 | CA2237900A1 Type ix collagen and chimeras |
| 05/22/1997 | CA2237818A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 05/22/1997 | CA2237783A1 E6 binding proteins |
| 05/22/1997 | CA2237641A1 Glial cell line-derived neurotrophic factor receptors |
| 05/22/1997 | CA2237581A1 Salmonella secreted proteins and uses thereof |
| 05/22/1997 | CA2237548A1 Crf analogs and their use in photoaffinity labeling of crf receptors |
| 05/22/1997 | CA2237392A1 Production of somatic mosaicism in mammals using a recombinatorial substrate |
| 05/22/1997 | CA2237299A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 05/22/1997 | CA2237214A1 Plant gene involved in auxin related signalling pathways |
| 05/22/1997 | CA2236076A1 The transcriptional promoter of the obesity gene |
| 05/22/1997 | CA2235710A1 Type ix collagen and fragments thereof |
| 05/22/1997 | CA2235695A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 05/22/1997 | CA2235629A1 Method for gene transfer into target cells with retrovirus |
| 05/22/1997 | CA2235628A1 Hybrid factor viii with modified activity |
| 05/22/1997 | CA2235334A1 Polyvalent anti-dengue vaccine |
| 05/22/1997 | CA2232876A1 Fas ligand fusion protein |
| 05/21/1997 | EP0774513A1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER |
| 05/21/1997 | EP0774512A2 A method for production of protein using molecular chaperon |
| 05/21/1997 | EP0774262A1 Pharmaceutical compositions comprising a neutralized virus and use thereof |
| 05/21/1997 | EP0774261A2 Uses of von Willebrand Factor and pharmaceutical preparations |
| 05/21/1997 | EP0774260A1 Remedy for corneal diseases |
| 05/21/1997 | EP0774120A1 Peptides marked with metal chelates |
| 05/21/1997 | EP0774119A1 Oligomer carrier molecules in which marker groups and haptens are selectively incorporated |
| 05/21/1997 | EP0774009A1 Process for preparing viruses and viral vectors |
| 05/21/1997 | EP0774005A1 Surface expression of enzyme in gene directed prodrug therapy |
| 05/21/1997 | EP0774003A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 05/21/1997 | EP0774002A1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 05/21/1997 | EP0774001A1 Production of tissue factor pathway inhibitor |